1.
|
We
note the disclosure on pages I and F-7 in your Form 10-K that your product
distribution spans across the Middle East and the Caribbean Islands, which
are regions that are generally understood to include Iran, Syria, Sudan,
and Cuba. Also, it appears from a dropdown menu on your website
that nationals of Cuba, Iran, Sudan, and Syria can contact you through
your website or telephone with questions related to your business or
products, Cuba, Iran, Sudan, and Syria are identified by the State
Department as state sponsors of terrorism, and are subject to U.S.
economic sanctions and export controls. We note that your Form
10-K does not include disclosure regarding contacts with Cuba, Iran,
Sudan, and Syria. Please describe to us the nature and extent
of your past, current, and anticipated contacts with the referenced
countries, if any, whether through distributors, resellers, or other
direct or indirect arrangements. Your response should describe
any products, equipment, components, technology, or services you have
provided to those countries, and any agreements, commercial arrangements,
or other contracts you have had with the governments of those countries or
entities controlled by those
governments.
|
2.
|
Please
discuss the materiality of any contacts with Cuba, Iran, Sudan, and Syria
described in response to the foregoing comment, and whether those contacts
constitute a material investment risk for your security
holders. You should address materiality in quantitative terms,
including the approximate dollar amounts of any associated revenues,
assets, and liabilities for the last three fiscal years. Also,
address materiality in terms of qualitative factors that a reasonable
investor would deem important in making an investment decision, including
the potential impact of corporate activities upon a company’s reputation
and share value. As you may be aware, various state and
municipal governments, universities, and other investors have proposed or
adopted divestment or similar initiatives regarding investment in
companies that do business with Undesignated state sponsors of
terrorism. Your materiality analysis should address the
potential impact of the investor sentiment evidenced by such actions
directed toward companies that have operations associated with Cuba, Iran,
Sudan, and Syria.
|
3.
|
We
note your disclosure that you sell your products to OEMs, VARs, selected
distributors and directly to end-users. Please tell us whether
you have considered including a separately captioned section that would
provide additional information regarding the distribution methods for your
products. See Item 10l(h)(4)(ii)of Regulation
S-K. For example, consider disclosing in future filings the
percentage of your products that you sell through each of your
distribution channels as well as whether you maintain an internal sales
force.
|
4.
|
We
note that you are in the process of outsourcing the majority of your
printer production to a company in China. Please describe your
contractual arrangements with this company and disclose the name of this
manufacturer. Please provide your analysis as to whether you
are required to file any agreements with this company as exhibits pursuant
to Item 601(b)(10) of Regulation
S-K.
|
5.
|
There
are many instances where two or more sources of a material change have
been identified, but the dollar amounts for each source that contributed
to the change were not disclosed. For instance, you state on
page 16-17 that the decrease in international banking and POS printer
shipments was due primarily to lower sales to distributors in Europe and
Asia, offset by an increase in printer sales to distributors in Latin
America, without quantifying the contributing and offsetting
factors. As another example, you state on pages 18 that
domestic revenue from TSG increased primarily due to increased sales of
consumable products and, to a lesser extent, higher maintenance and repair
services offset by a decline in sales of replacement parts for legacy
printers. Tell us what consideration you gave to quantifying
each contributing factor, including offsetting factors, relating to a
material change pursuant to the requirements of Instruction 4 to Item
303(a) of Regulation S-K and the related interpretative guidance In
Section III.D. of SEC Release
33-6835.
|
6.
|
We
note that you have provided little information concerning the pricing
environment for the products and services sold over the last three
years. Tell us what consideration you gave to discussing in
quantified terms the extent to which material changes in revenue were due
to changes in volume versus changes in pricing or to the introduction of
new products. See Item 303(a)(3)(iii) of Regulation
S-K.
|
7.
|
You
disclose that the increase in gross profit and gross margin was “somewhat
offset by a less favorable sales mix without further
explanation. Please tell us in quantitative and qualitative
terms, and disclose in future filings as applicable, the reasons for the
changes in product mix and the ways in which the mix proved less
favorable.
|
8.
|
We
note your disclosures regarding limitations on effectiveness of controls
and your statement that a “control system, no matter how well conceived
and operated, can provide only reasonable, not absolute, assurance that
the control system’s objectives will be met.” Please confirm,
if true, that the Company’s disclosure controls and procedures are
designed to provide reasonable assurance of achieving their objectives and
that if your CEO and CFO concluded that your controls and procedures are
effective at the reasonable assurance level. In the
alternative, remove the reference to the level of assurance of your
disclosure controls and procedures. Please refer to Section
II.F.4 of Management’s Reports on Internal Control Over Financial
Reporting and Certification of Disclosure in Exchange Act Periodic
Reports, SEC Release No. 33-8238, available on our website at http://www.sec.gov/rules/final/33-8238.htm.
|
9.
|
You do not appear to have
included the information required by Item 308(c) of Regulation S-K in your
Form 10-K. Please tell us whether or not there were changes in
your internal controls over financial reporting during last fiscal
quarter that have materially affected or are reasonably likely to
materially affect the Company’s internal controls over financial
reporting. In addition, ensure that future reports include the
information required by Item 308(c) of Regulation
S-K.
|
10.
|
We
note from your disclosures on page 1 that the Company provides maintenance
and warranty services and markets the sale of consumable products through
the TransAct Services Group. We further note that this Group
accounted for approximately 19.8% and 25.4% of the Company’s total net
sales in fiscal 2008 and 2007, respectively. Tell us how you
considered presenting separate line items for product and service revenues
and the related cost of revenues pursuant to Article 5-03(b)(l) and (2) of
Regulation S-X.
|
11.
|
We
note that the Company’s net inventory included a reserve of $3,050,000 and
$2,850,000 at December 31, 2008 and 2007, respectively. With
regards to your inventory valuation, tell us how you considered Chapter 4
footnote 2 of ARB 43 and SAB Topic 5(BB), which indicates that inventory
write-downs due to obsolescence establish a new cost basis and should not
be presented as a reserve. Tell us whether inventory previously
written down to the estimated net realizable value is ever written back up
due to changes in future demand and market
conditions. Additionally, tell us whether any such inventory
was subsequently sold and resulted in a higher gross margin due to the
previous write-downs and if so, whether such sales were material to the
years presented in your financial
statements.
|
12.
|
We
note from your disclosures on page 6 that the Company sells its products
through resellers (i.e. OEMs and distributors). Please explain
your revenue, recognition policy for products sold through your
resellers. For instance, tell us whether revenue from your
resellers is recognized on a sell-in or sell through basis. If
your policy differs amongst resellers, then please explain
why. Also, if you recognize revenue on a sell through basis,
then tell us how you account for inventory upon delivery to the resellers
and tell us the amount of inventory held at resellers for each period
presented. Further, tell us how you considered including a
discussion of your revenue recognition policy as it relates to indirect
sales in your footnote disclosures.
|
13.
|
We
note that on May 14, 2008, the Company signed a Patent License and
Settlement Agreement with FutureLogic that settled the current patent
litigation and all other legal matters outstanding between the two
parties. Please tell us whether the Company received any
settlements funds in exchange for the license to your dual port technology
and if so, please tell us how you accounted for this settlement and how
you classified such funds in your financial
statements.
|
14.
|
We
believe the non-GAAP operating statement columnar format appearing in the
Form 8-K filed on March 10, 2009 (Exhibit 99.1) may create the unwarranted
impression to investors that the non-GAAP operating statement has been
prepared under another comprehensive set of accounting rules or principles
while also conveying undue prominence to a statement based on non-GAAP
measures. In addition, Section II.A.2 of SEC Release 33-8176
defines non-GAAP measures and does not contemplate including non-GAAP
financial statements as a “measure.” Please remove that presentation, or
explain to us in reasonable detail why its retention is justified in light
of these concerns. As a substitute for this presentation
format, you may consider presenting only individual non-GAAP measures
(i.e., line items, subtotals, etc.) provided each one compiles with Item
10(e)(l)(i) of Regulation S-K, Regulation G and the Division of
Corporation Finance’s Frequently Asked Questions Regarding Use of Non-GAAP
Financial Measures, Question 8.
|
15.
|
We
note your use of non-GAAP measures in the Form 8-K filed March 10, 2009,
which excludes a number of items that appear to be recurring in
nature. Tell us how you considered Question 8 of Frequently
Asked Questions Regarding the Use of Non-GAAP Financial Measures to
include the following disclosures:
|
·
|
the
economic substance behind management’s decision to use such a
measure;
|
·
|
the
material limitations associated with use of the non-GAAP financial measure
as compared to the use of the most directly-comparable GAAP financial
measure;
|
·
|
the
manner in which management compensates for these limitations when using
the non-GAAP financial measure; and
|
·
|
the
substantive
reasons why management believes the non-GAAP financial measure provides
useful information to investors.
|